Geneos Wealth Management’s CACI CACI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.2K Buy
71
+24
+51% +$13.8K ﹤0.01% 1754
2026
Q2
$21.8K Hold
47
– – ﹤0.01% 1766
2026
Q1
$25.6K Hold
47
– – ﹤0.01% 1683
2025
Q4
$25K Buy
47
+8
+21% +$4.52K ﹤0.01% 1653
2025
Q3
$19.5K Sell
39
-56
-59% -$27.1K ﹤0.01% 1733
2025
Q2
$45.3K Buy
95
+34
+56% +$15.1K ﹤0.01% 1628
2025
Q1
$22.4K Buy
61
+29
+91% +$11.1K ﹤0.01% 1898
2024
Q4
$12.9K Buy
32
+9
+39% +$4.39K ﹤0.01% 1936
2024
Q3
$11.6K Buy
+23
New +$10.6K ﹤0.01% 1778
2022
Q2
– Sell
-14
Closed -$4K – 2607
2022
Q1
$4K Buy
+14
New +$3.86K ﹤0.01% 2382
2020
Q4
– Sell
-12
Closed -$2K – 2900
2020
Q3
$2K Buy
+12
New +$2.59K ﹤0.01% 2388

Other funds holding CACI

Geneos Wealth Management's CACI Position: Q3 2026 in Review

Geneos Wealth Management increased its CACI (CACI) stake by 51% in Q3 2026, buying an estimated $13.8K and bringing the position to 71 shares worth $43.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

Geneos Wealth Management first reported a position in CACI in Q3 2020 and has held it in 11 quarters since. The position peaked at $45.3K in Q2 2025. 383 funds tracked by Wall St. Rank hold CACI as of Q3 2026.

  • Geneos Wealth Management held 71 shares of CACI worth $43.2K as of Q3 2026.
  • Geneos Wealth Management bought 24 CACI shares in Q3 2026, an estimated $13.8K.
  • CACI made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #1754 holding.
  • Geneos Wealth Management first reported a position in CACI in Q3 2020 and has held it in 11 quarters since.
  • Geneos Wealth Management's CACI position peaked at $45.3K in Q2 2025.
  • 383 funds tracked by Wall St. Rank held CACI as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.